CGNH Projected Dividend Yield
CardioGenics Holdings Inc. ( OTCBB : CGNH )CardioGenics Holdings is engaged in the development of products targeting the immunoassay segment of the point-of-care (POC) in vitro diagnostic testing market. Co.'s products include: QL Care Analyzer, which is an automated POC immunoassay analyzer; Cardiovascular Tests, which are series of immunoassay test products to detect cardiac markers, including Troponin I, Plasminogen Activator Inhibitor Type-1, Heart Failure Risk Stratification, and Heart Failure Genomics Risk; and Paramagnetic Beads, which are developed through its proprietary method, which improves their light collection. 21 YEAR PERFORMANCE RESULTS |
CGNH Dividend History Detail CGNH Dividend News CGNH Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |